Free Trial

Atb Cap Markets Has Pessimistic Outlook of NOV Q3 Earnings

NOV logo with Energy background

Key Points

  • Atb Cap Markets has reduced its Q3 2025 EPS estimate for NOV from $0.29 to $0.25, while the consensus for the full year remains at $1.40 per share.
  • Multiple investment firms have cut their target prices for NOV, with Morgan Stanley lowering it to $15.00 and Goldman Sachs to $13.00, reflecting a cautious outlook from analysts.
  • NOV has a current dividend yield of 3.63% with a payout ratio of 20.00%, signaling stable dividend distributions amid fluctuating stock performance.
  • MarketBeat previews top five stocks to own in September.

NOV Inc. (NYSE:NOV - Free Report) - Stock analysts at Atb Cap Markets lowered their Q3 2025 earnings per share (EPS) estimates for NOV in a report released on Tuesday, July 29th. Atb Cap Markets analyst W. Syed now expects that the oil and gas exploration company will earn $0.25 per share for the quarter, down from their previous estimate of $0.29. The consensus estimate for NOV's current full-year earnings is $1.40 per share. Atb Cap Markets also issued estimates for NOV's Q4 2025 earnings at $0.27 EPS, FY2025 earnings at $0.99 EPS, Q1 2026 earnings at $0.22 EPS, Q2 2026 earnings at $0.29 EPS, Q3 2026 earnings at $0.33 EPS, FY2026 earnings at $1.17 EPS, Q1 2027 earnings at $0.24 EPS, Q2 2027 earnings at $0.32 EPS and FY2027 earnings at $1.34 EPS.

NOV (NYSE:NOV - Get Free Report) last released its earnings results on Monday, July 28th. The oil and gas exploration company reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.30 by ($0.01). NOV had a net margin of 5.36% and a return on equity of 7.25%. The company had revenue of $2.19 billion during the quarter, compared to analyst estimates of $2.16 billion. During the same period in the previous year, the company posted $0.57 EPS. The company's quarterly revenue was down 1.3% compared to the same quarter last year.

Several other research firms have also weighed in on NOV. Morgan Stanley cut their target price on NOV from $18.00 to $15.00 and set an "overweight" rating on the stock in a research note on Friday, May 16th. Piper Sandler lowered their price target on NOV from $18.00 to $16.00 and set a "neutral" rating for the company in a report on Thursday, May 1st. Wells Fargo & Company lowered their price target on NOV from $11.00 to $10.00 and set an "underweight" rating for the company in a report on Thursday, June 5th. JPMorgan Chase & Co. downgraded NOV from an "overweight" rating to a "neutral" rating and lowered their price target for the stock from $17.00 to $15.00 in a report on Wednesday. Finally, Barclays lowered their price target on NOV from $13.00 to $11.00 and set an "underweight" rating for the company in a report on Wednesday, April 30th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, NOV currently has an average rating of "Hold" and a consensus target price of $16.69.

Get Our Latest Stock Analysis on NOV

NOV Trading Down 3.5%

NYSE:NOV traded down $0.44 during mid-day trading on Thursday, hitting $12.14. The company had a trading volume of 4,160,059 shares, compared to its average volume of 4,032,447. NOV has a fifty-two week low of $10.84 and a fifty-two week high of $19.35. The business's fifty day moving average is $13.04 and its two-hundred day moving average is $13.60. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.76 and a current ratio of 2.58. The firm has a market cap of $4.51 billion, a P/E ratio of 9.95, a P/E/G ratio of 3.36 and a beta of 1.32.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of NOV. Mirae Asset Global Investments Co. Ltd. bought a new position in NOV in the first quarter valued at approximately $36,000. Exchange Traded Concepts LLC grew its stake in NOV by 382.9% in the first quarter. Exchange Traded Concepts LLC now owns 18,201 shares of the oil and gas exploration company's stock valued at $277,000 after purchasing an additional 14,432 shares in the last quarter. GAMMA Investing LLC grew its stake in NOV by 172.9% in the first quarter. GAMMA Investing LLC now owns 4,320 shares of the oil and gas exploration company's stock valued at $66,000 after purchasing an additional 2,737 shares in the last quarter. Envestnet Asset Management Inc. grew its stake in NOV by 15.1% in the first quarter. Envestnet Asset Management Inc. now owns 669,077 shares of the oil and gas exploration company's stock valued at $10,183,000 after purchasing an additional 87,909 shares in the last quarter. Finally, UMB Bank n.a. grew its stake in NOV by 66.7% in the first quarter. UMB Bank n.a. now owns 3,895 shares of the oil and gas exploration company's stock valued at $59,000 after purchasing an additional 1,558 shares in the last quarter. 93.27% of the stock is currently owned by institutional investors.

NOV Announces Dividend

The company also recently disclosed a dividend, which was paid on Friday, June 13th. Investors of record on Tuesday, June 3rd were issued a dividend of $0.21 per share. The ex-dividend date was Monday, June 2nd. This represents a dividend yield of 363.0%. NOV's dividend payout ratio (DPR) is presently 24.59%.

NOV Company Profile

(Get Free Report)

NOV Inc designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors in the United States and internationally. It operates through two segments, Energy Equipment, and Energy Products and Services. The company provides solids control and waste management equipment and services, managed pressure drilling, drilling fluids, premium drillpipe, wired pipe, drilling optimization services, tubular inspection and coating services, instrumentation, downhole tools, and drill bits.

See Also

Earnings History and Estimates for NOV (NYSE:NOV)

Should You Invest $1,000 in NOV Right Now?

Before you consider NOV, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NOV wasn't on the list.

While NOV currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines